Centers in San Antonio, other Texas cities are out of the only antibody effective against omicron

A technician fills wells with monoclonal antibodies for a research test. - PUBLIC DOMAIN / LINDA BARTLETT
Public Domain / Linda Bartlett
A technician fills wells with monoclonal antibodies for a research test.
The Texas Department of State Health Services says its regional infusion centers in San Antonio and four other cities have run out of the only monoclonal antibody treatment believed effective against COVID-19's surging omicron variant.

Those infusion centers — also located in Austin, El Paso, Fort Worth and The Woodlands — won't be able offer the treatment sotrovimab until federal authorities ship additional supply to Texas in January. The department said the treatment is running short nationwide.

DSHS will notify people with appointments scheduled for
sotrovimab to let them know about their inability to provide the treatment. The centers in San Antonio and other locations with the outages will continue to offer other antibodies for people diagnosed with non-Omicron cases of COVID-19.

The Omicron variant now accounts for more than 90% percent of new cases, according to DSHS.

People with COVID-19 infections at high risk of hospitalization and death should contact their health care provider to discuss treatment options, according to the agency.

Stay on top of San Antonio news and views. Sign up for our Weekly Headlines Newsletter.

Scroll to read more San Antonio News articles
Join the San Antonio Current Press Club

Local journalism is information. Information is power. And we believe everyone deserves access to accurate independent coverage of their community and state.
Help us keep this coverage going with a one-time donation or an ongoing membership pledge.


Join SA Current Newsletters

Subscribe now to get the latest news delivered right to your inbox.